Medicare

Medicare spending $9B on hepatitis C drugs
Medicare spending $9B on hepatitis C drugs
Medicare spending $9B on hepatitis C drugs
Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to new government figures. That's raising insurance costs for all beneficiaries, whether or not they have the liver-wasting viral disease.

Load More Articles